Cognetivity Neurosciences provides update on 2021 corporate achievements
Ryan Allway January 11th, 2022 Psychedelics Company poised for rapid expansion in 2022 after highly successful 2021, in which it secured commercial deployments across three continents, US FDA registration and multiple awards for innovation in AI VANCOUVER, BC, Jan. 11, 2022 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE:... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )